The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most trusted and recognized consumer brand names, including its namesake bleach and cleaning products; Pine-Sol® cleaners; Liquid-Plumr® clog removers; Poett® home care products; Fresh Step® cat litter; Glad® bags and wraps; Kingsford® charcoal; Hidden Valley® dressings and sauces; Brita® water-filtration products; Burt's Bees® natural personal care products; and RenewLife®, Rainbow Light®, Natural Vitality Calm™, NeoCell® and Stop Aging Now® vitamins, minerals and supplements. The company also markets industry-leading products and technologies for professional customers, including those sold under the CloroxPro™ and Clorox Healthcare® brand names. More than 80% of the company's sales are generated from brands that hold the No. 1 or No. 2 market share positions in their categories.

Company profile
Ticker
CLX
Exchange
Website
CEO
Benno Dorer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
6570 Donlon Group, LLC • A & M Products Manufacturing Company • Andover Properties, Inc. • Iodine Holdings, Inc. • Brita Canada Corporation • Brita Canada Holdings Corporation • Brita LP • Brita Manufacturing Company • The Brita Products Company • Burt’s Bees, Inc. ...
IRS number
310595760
CLX stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-Q
2023 Q2
Quarterly report
2 Feb 23
8-K
Clorox Reports Q2 Fiscal Year 2023 Results, Updates Outlook
2 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
17 Nov 22
10-Q
2023 Q1
Quarterly report
1 Nov 22
8-K
Clorox Reports Q1 Fiscal Year 2023 Results, Confirms Outlook
1 Nov 22
DEFA14A
Additional proxy soliciting materials
5 Oct 22
DEF 14A
Definitive proxy
5 Oct 22
10-K
2022 FY
Annual report
10 Aug 22
8-K
Clorox Reports Q4 and FY22 Results, Provides FY23 Outlook and Announces Streamlined Operating Model
3 Aug 22
SD
Conflict minerals disclosure
26 May 22
Transcripts
CLX
Earnings call transcript
2023 Q2
2 Feb 23
CLX
Earnings call transcript
2023 Q1
2 Nov 22
CLX
Earnings call transcript
2022 Q4
4 Aug 22
CLX
Earnings call transcript
2022 Q3
3 May 22
CLX
Earnings call transcript
2022 Q2
4 Feb 22
CLX
Earnings call transcript
2022 Q1
2 Nov 21
CLX
Earnings call transcript
2021 Q4
4 Aug 21
CLX
Earnings call transcript
2021 Q3
30 Apr 21
CLX
Earnings call transcript
2021 Q2
5 Feb 21
CLX
Earnings call transcript
2021 Q1
2 Nov 20
Latest ownership filings
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jun 22 | Jun 21 | Jun 20 | Jun 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 170.00 mm | 170.00 mm | 170.00 mm | 170.00 mm | 170.00 mm | 170.00 mm |
Cash burn (monthly) | 36.67 mm | 2.17 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 104.22 mm | 6.16 mm | n/a | n/a | n/a | n/a |
Cash remaining | 65.78 mm | 163.84 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | 1.8 | 75.6 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
56.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1068 |
Opened positions | 146 |
Closed positions | 94 |
Increased positions | 361 |
Reduced positions | 366 |
13F shares | Current |
---|---|
Total value | 13.93 tn |
Total shares | 99.36 mm |
Total puts | 1.91 mm |
Total calls | 1.72 mm |
Total put/call ratio | 1.1 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 15.15 mm | $2.13 tn |
BLK Blackrock | 9.27 mm | $1.30 tn |
STT State Street | 8.83 mm | $1.24 tn |
WFC Wells Fargo & Co. | 3.60 mm | $505.85 bn |
Geode Capital Management | 2.62 mm | $369.26 bn |
SF Stifel Financial | 2.46 mm | $345.11 bn |
FHI Federated Hermes | 2.23 mm | $313.42 bn |
RY Royal Bank Of Canada | 1.84 mm | $258.49 bn |
NTRS Northern Trust | 1.81 mm | $254.05 bn |
MS Morgan Stanley | 1.80 mm | $252.67 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Mar 23 | Stacey Grier | Common Stock | Payment of exercise | Dispose F | No | No | 153.79 | 41 | 6.31 k | 6,596 |
2 Mar 23 | Rendle Linda J | Common Stock | Payment of exercise | Dispose F | No | No | 156.48 | 7,713 | 1.21 mm | 44,758 |
2 Mar 23 | Rendle Linda J | Common Stock | Option exercise | Acquire M | No | No | 84.45 | 2,935 | 247.86 k | 52,471 |
2 Mar 23 | Rendle Linda J | Common Stock | Option exercise | Acquire M | No | No | 89.82 | 7,850 | 705.09 k | 49,536 |
2 Mar 23 | Rendle Linda J | Stock Option Common Stock | Option exercise | Dispose M | No | No | 89.82 | 7,850 | 705.09 k | 0 |
2 Mar 23 | Rendle Linda J | Stock Option Common Stock | Option exercise | Dispose M | No | No | 84.45 | 2,935 | 247.86 k | 0 |
30 Dec 22 | Esther Lee | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 1,073.319 | 0.00 | 10,654.784 |
30 Dec 22 | Fleischer Spencer C | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 219.126 | 0.00 | 12,933.98 |
30 Dec 22 | Fleischer Spencer C | Deferred Stock Units Common Stock | Grant | Acquire A | No | No | 0 | 1,073.319 | 0.00 | 12,714.854 |
30 Dec 22 | Paul Gray Parker | Common Stock | Grant | Acquire A | No | No | 140.33 | 55 | 7.72 k | 366 |
News
Deutsche Bank Maintains Hold on Clorox, Lowers Price Target to $147
20 Mar 23
Barclays Maintains Underweight on Clorox, Lowers Price Target to $108
6 Feb 23
'Risk Of Overheating': 4 Experts On Hot January Jobs Report, How The Fed Will React
3 Feb 23
Clorox's Return On Capital Employed Overview
3 Feb 23
Morgan Stanley Maintains Equal-Weight on Clorox, Raises Price Target to $145
3 Feb 23
Press releases
The Clorox Company Named Barron's Most Sustainable U.S. Company
2 Mar 23
KINGSFORD® OPENS APPLICATIONS FOR THIRD YEAR OF PRESERVE THE PIT® FELLOWSHIP
28 Feb 23
CloroxPro Expands CloroxPro HealthyClean® Online Learning Platform Offerings
28 Feb 23
Clorox Declares Regular Quarterly Dividend of $1.18 Per Share
14 Feb 23
Clorox to Present at 2023 CAGNY Conference
6 Feb 23